How do you treat a patient with synchronous locally advanced lung and head and neck cancers?  

Does the availability of first line checkpoint inhibitor therapy affect your treatment decision? 



Answer from: Radiation Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution